Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$3.49 - $4.26 $10 - $12
-3 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$3.94 - $5.81 $11 - $17
3 New
3 $0
Q1 2021

May 24, 2021

SELL
$2.59 - $9.26 $7 - $27
-3 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$5.66 - $8.7 $16 - $26
3 New
3 $0

Others Institutions Holding BNTC

About Benitec Biopharma Inc.


  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $299M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.